Sun Pharma slips 4% as one-time exceptional cost leads to surprise Q4 net loss
indiatimes.com
economics
2022-05-31 05:10:45

Stock Analysis – Know before investing Stock score of Sun Pharmaceutical Industries Ltd moved down by 1 in a month on a 10-point scale. Subscribe Now Exclusively for

Stock Analysis Stock score of Sun Pharmaceutical Industries Ltd is 8 on a scale of 10. View Stock Analysis »

NEW DELHI – Shares of Sun Pharmaceuticals slid 3.5 per cent in early trade on Tuesday as the drugmaker reported an unexpected net loss of Rs 2,277 crore in the March 2022 quarter on account of a one-time exceptional cost.The Mumbai-based drug major had reported a net profit of Rs 894 crore in the January-March period of 2020-21.
